AIMOVIG (erenumab) has been registered in Australia as the first and only treatment targeting the calcitonin gene-related peptide (CGRP) receptor for the prophylaxis of migraine in adults, providing a new and specifically targeted preventive approach.
THE Australian Competition and Consumer Commission (ACCC) has announced it will not oppose the proposed merger between Sigma Healthcare Limited and Chemist Warehouse Group, contingent upon a court-enforceable undertaking provided by Sigma (PD breaking news).
THE Australian Pharmacy Council (APC) has welcomed the release of the Unleashing the Potential of our Health Workforce – Scope of Practice Review final report, emphasising its workforce development recommendations.
AHEAD of Whooping Cough Day tomorrow, TerryWhite Chemmart (TWC) has announced a five-year partnership with the Immunisation Foundation of Australia (IFA) to boost awareness on essential vaccines, with a particular emphasis on whooping cough (pertussis), as well as RSV, MMR, and influenza.